Share This Article:

Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa

Abstract PP. 1-5
DOI: 10.4236/oalib.1100855    1,197 Downloads   1,618 Views   Citations

ABSTRACT

Background: Measurement of Viral Load (VL) is the most reliable mean for evaluating virological monitoring of the Human Immunodeficiency Virus (HIV) infection. It allows determination of the amount of virus present in a given volume. Due to the constraints of costs, the VL is not often requested for patient’s follow-up in countries with limited resources. Hence the objective of this study is to implement an in-house Quantitative Real-Time PCR to assess the VL of HIV infected patients in Kinshasa. Methods: One hundred and fifty five patients positive for HIV type 1, naive of Antiretroviral Therapy (ART) and eligible for treatment were included in the study. Five milliliter of blood was collected in a tube with anticoagulant. One milliliter of plasma was sent to the laboratory for analysis. After RNA extraction, a Quantitative Real time PCR was performed on a portion of the region of the Long Terminal Repeat (LTR) of the virus. Results: Of 155 samples received for determination of VL by Quantitative Real-Time PCR, 153 were successfully amplified according to the protocol. The median VL was 301052.97 copies/ml or 5.48 log10. Conclusions: The results of VL were used to assess the feasibility of the Real-Time Quantitative PCR. It turns a simple, reliable and less expensive alternative for the diagnosis and virological monitoring of HIV patients under ART.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Erick, K. , Adawaye, C. , Raphael, B. , Richard, K. , Georges, M. , Patrick, D. , Dolores, V. and Pierre, H. (2014) Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa. Open Access Library Journal, 1, 1-5. doi: 10.4236/oalib.1100855.

References

[1] World Health Organization. Towards Universal Access by 2010. How WHO Is Working with Countries to Scale-Up HIV Prevention, Treatment, Care and Support. World Health Organization, Geneva, 2006. www.who.int/hiv/universalaccess2010/en
[2] (2010) World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach (2010 Revision). World Health Organization, Geneva. www.who.int/publications/2010/9789241599764_eng.pdf
[3] (2012) Médecins Sans Frontières. Undetectable-How Viral Load Monitoring Can Improve HIV Treatment in Developing Countries. Médecins Sans Frontières, Geneva. www.msfaccess.org/content/undetectable-how-viral-load-monitoring-can-improve-hiv-treatment-developing-countries
[4] Boyer, S., March, L., Kouanfack, C., Laborde-Balen, G., Marino, P., Fobang, A.A., Mpoudi-Ngole, E., Koulla-Shiro, S., Delaporte, E., Carrieri, M.P., Spire, B., Laurent, C.C. and Moatti, J.P., on Behalf of the Stratall ANRS 12110/ ESTHER Study Group (2013) Monitoring of HIV Viral Load, CD4 Cell Count, and Clinical Assessment Versus Clinical Monitoring Alone for Antiretroviral Therapy in Low-Resource Settings (Stratall ANRS 12110/ESTHER): A Cost-Effectiveness Analysis. The Lancet Infectious Diseases, 13, 577-586.
http://dx.doi.org/10.1016/S1473-3099(13)70073-2
[5] (2010) Integrated Regional Information Networks (IRIN) Afrique: L’échec thérapeutique trop souvent mal détecté. www.irinnews.org/fr
[6] Kamangu, N.E., Kalala, N.H. and Mesia, K.G. (2012) Profile of Antiretroviral Treatment Centers in Kinshasa, Democratic Republic of Congo [Poster 388]. Proceedings of the 1st International African Society of Laboratory Medicine (ASLM) Conference, 1-7 December 2012, Cape Town, 377.
[7] (2008) Programme National de Lutte contre le VIH/SIDA et les Infections Sexuellement Transmissibles (PNLS), Ministère de la Santé Publique, République Démocratique du Congo. Guide National de traitement de l’infection à VIH par les ARV chez l’adolescent et l’adulte.
[8] (2010) QIAGEN: QIAamp? RNA Mini and Blood Mini Handbook. 3rd Edition, 27-29.
[9] Rouet, F., Chaix, M.L., Nerrienet, E., Ngo-Giang-Huong, N., Plantier, J.C., Burgard, M., Peeters, M., Damond, F., Koumavi, E.D., Msellati, P., Ferradini, L., Rukobo, S., Maréchal, V., Schvachsa, N., Wakrim, L., Rafalimanana, C., Rakotoambibiba, B., Viard, J.P., Seigneurin, J.M. and Rouzioux, C., for the Agence Nationale de Recherchessur le SIDA AC11/AC12 Working Groups (2007) Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test. Journal of Acquired Immune Deficiency Syndrome, 45, 380-388.
http://dx.doi.org/10.1097/QAI.0b013e3180640cf5
[10] Steegen, K., Luchters, S.S., De Cabooter, N., Reynaerts, J., Mandaliya, K., Plum, J., Jaoko, W., Verhofstede, C. and Temmerman, M. (2007) Evaluation of Two Commercially Available Alternatives for HIV-1 Viral Load Testing in Resource-Limited Settings. Journal of Virological Methods, 146, 178-187.
http://dx.doi.org/10.1016/j.jviromet.2007.06.019
[11] Rouet, F., Foulongne, V., Viljoen, J., Steegen, K., Becquart, P., Valéa, D., Danaviah, S., Segondy, M., Verhofstede, C., Van de Perre, P., for the WHO/ANRS 1289 Kesho Bora Study Group (2010) Comparison of the Generic HIV Viral Load? Assay with AmplicorTM HIV-1 Monitoring v1.5 and Nuclisens HIV-1 EasyQ? v1.2 Techniques for Plasma HIV-1 RNA Quantification of Non-B Subtypes: The Kesho Bora Preparatory Study. Journal of Virological Methods, 163, 253-257.
http://dx.doi.org/10.1016/j.jviromet.2009.10.005
[12] Applied Biosystems. www.appliedbiosystems.com
[13] Drosten, C., Panning, M., Drexler, J.F., H?nsel, F., Pedrosoc, C., Yeats, J., de Souza Luna, L.K., Samuel, M., Liedigk B., Lippert, U., Stürmer, M., Doerr, H.W., Brites, C. and Preiser ,W. (2006) Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for 5’ Long Terminal Repeat Domain. Clinical Chemistry, 52, 1258-1266.
http://dx.doi.org/10.1373/clinchem.2006.066498
[14] Biocentric. www.biocentric.com/
[15] Rouet, F. and Rouzioux, C. (2007) The Measurement of HIV-1 Viral Load in Resource-Limited Settings: How and Where? Clinical Laboratory, 53, 135-148.
[16] Kamangu, E., Chatté, A., Boreux, R., Susin, F., Kalala, R., Mvumbi, G., Vaira, D. and Hayette, M.P. (2014) Comparaison d’une PCR Quantitative Maison en Temps Réel et du COBAS/Ampliprep TaqMan de Roche pour la détermination de la Charge Virale des Variantes du VIH Type 1 non-B.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.